QUOTE AND NEWS
StreetInsider.com  May 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Aastrom+Biosciences%2C+Inc.+%28ASTM%29+Posts+Q1+Loss+of+15cShare/8319165.html for the full story.
StreetInsider.com  Mar 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Aastrom+Biosciences%2C+Inc.+%28ASTM%29+Tops+Q4+EPS+by+5c/8193356.html for the full story.
StreetInsider.com  Aug 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Aastrom+Biosciences%2C+Inc.+%28ASTM%29+Posts+Q2+Loss+of+26cShare/6718343.html for the full story.
Globe Newswire  May 31  Comment 
ANN ARBOR, Mich., May 31, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced the
Globe Newswire  May 11  Comment 
ANN ARBOR, Mich., May 11, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded, patient-specific cellular therapies for the treatment of severe, chronic cardiovascular diseases, announces the following
Globe Newswire  Nov 1  Comment 
ANN ARBOR, Mich., Nov. 1, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) announces the following webcast: What: Aastrom Biosciences, Inc., First Quarter Fiscal Year 2011 Investor Conference Call                     When:
Globe Newswire  Aug 5  Comment 
ANN ARBOR, Mich., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) announces the following webcast: What: Aastrom Biosciences, Inc. Fourth Quarter Fiscal Year 2010 Investor Conference Call When: Tuesday, August 17, 2010 @ 4:00
Globe Newswire  Aug 2  Comment 
ANN ARBOR, Mich., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) today announced that it currently plans to hold its 2010 Annual Meeting of Shareholders on October 21, 2010. Shareholders of record as of August 26, 2010 are
Globe Newswire  Mar 4  Comment 
ANN ARBOR, Mich., March 4, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTMD), a leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported that the company has regained
StreetInsider.com  Feb 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Aastrom+Biosciences%2C+Inc.+%28ASTM%29+Posts+In-Line+Q2+Loss+of+%240.03%3B+Revs+Lower+YY/5326998.html for the full story.





 



References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki